Stock NOVABAY PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar NovaBay Pharmaceuticals, Inc. Nyse

Equities

US66987P1021

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for NovaBay Pharmaceuticals, Inc.
05-09 NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-09 Earnings Flash (NBY) NOVABAY PHARMACEUTICALS Reports Q1 Revenue $2.63M, vs. Street Est of $3.28M MT

Chart calendar NovaBay Pharmaceuticals, Inc.

8957aec54bc32b3a66aa2f5c063.2tSuyMXvMYUY-neTfrdZK2Fmht5njzbOwVMJUwwab6U.spDLoZO5YvNxnDv5FY8KZBQU6bsIxEX4mT1YFkZYCfzvgNq9gblSvSDLIg~88d7af009d229d52d580acf211b53ce9

Upcoming events on NovaBay Pharmaceuticals, Inc.

07/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on NovaBay Pharmaceuticals, Inc.

28/05/2024 19:00 Annual General Meeting
09/05/2024 21:30 Q1 2024 Earnings Call
09/05/2024 21:05 Q1 2024 Earnings Release
26/03/2024 20:30 Q4 2023 Earnings Call
26/03/2024 20:05 Q4 2023 Earnings Release
15/11/2022 Reverse Split: 1 of 35
11/08/2022 21:30 Interim 2022 Earnings Call
11/08/2022 21:05 Interim 2022 Earnings Release
12/05/2022 21:30 Q1 2022 Earnings Call
12/05/2022 21:05 Q1 2022 Earnings Release
29/03/2022 21:30 FY 2021 Earnings Call
29/03/2022 21:05 FY 2021 Earnings Release
31/01/2022 19:00 Extraordinary Shareholders Meeting - Third Call
13/01/2022 Extraordinary Shareholders Meeting - Second Call
10/01/2022 12:00 H.C. Wainwright BioConnect Conference
16/12/2021 Extraordinary Shareholders Meeting - First Call
11/11/2021 21:30 Q3 2021 Earnings Call
11/11/2021 21:05 Q3 2021 Earnings Release
29/09/2021 21:30 Acquisition of DERMAdoctor, LLC by NovaBay® Pharmaceuticals, Inc Call
12/09/2021 H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		6,60
6,97
-5.32%		9,93
10,5
-5.39%		8,42
9,14
-7.82%		14,4
14,2
1.22%		14,7
14,4
2.26%
14,8

EBITDA
Million USD		Released
Forecast
Spread 		-9,34
-8,30
-12.47%		-6,38
-5,70
-11.84%		-8,74
-6,80
-28.57%		-7,20
-4,50
-59.93%		-7,39
-5,50
-34.42%
-2,60

EBIT
Million USD		Released
Forecast
Spread 		-9,40
-8,99
-4.56%		-6,43
-6,48
0.76%		-8,86
-8,59
-3.17%		-7,68
-5,76
-33.33%		-7,60
-6,20
-22.52%
-3,35

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,65
-8,79
-9.81%		-11,0
-11,1
0.86%		-5,82
-8,59
32.16%		-10,6
-5,97
-77.84%		-9,64
-9,50
-1.47%
-3,35

Net income
Million USD		Released
Forecast
Spread 		-10,5
-8,80
-19.24%		-11,0
-11,1
0.82%		-6,56
-8,59
23.6%		-16,3
-5,97
-172.67%		-16,7
-9,50
-75.76%
-3,35

EPS
USD		Released
Forecast
Spread 		-588
-521
-12.94%		-380
-392
3.12%		-184
-221
16.67%		-353
-142
-149.38%		-139
-80,9
-71.43%
-9,45

Announcement Date26/03/2025/03/2129/03/2230/03/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		2,63
3,26
-19.36%		3,05
3,51
-13.25%		3,83
3,74
2.3%		3,64
4,73
-22.98%		3,12
3,20
-2.38%		4,61
3,68
25.44%		3,27
3,55
-7.9%		3,73
3,40
9.62%		2,63
3,28
-19.79%
3,58


3,71


4,24


4,39


4,78

EBITDA
Million USD		Released
Forecast
Spread 		-2,35
-3,10
24.13%		-2,03
-2,30
11.65%		-0,34
-1,30
74%		-2,57
0,00
- 		-1,68
-1,80
6.5%		-1,30
-1,60
18.5%		-1,07
-1,40
23.93%		-3,34
-1,60
-108.81%		-2,42
-1,10
-120.36%
-0,90


-0,50


-0,20


0,10


0,10

EBIT
Million USD		Released
Forecast
Spread 		-2,38
-2,90
17.72%		-2,15
-2,53
14.94%		-0,46
-1,95
76.56%		-2,69
-0,76
-253.82%		-1,73
-2,10
17.43%		-1,36
-2,09
35.17%		-1,12
-1,65
32.16%		-3,39
-2,00
-69.55%		-2,44
-1,32
-84.55%
-1,08


-0,71


-0,24


-0,36


-0,11

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-0,11
-2,15
94.83%		-2,16
-2,38
9.45%		-0,14
-1,80
92.44%		-8,21
-0,76
-979.74%		-1,74
-2,10
17.19%		-2,04
-2,09
2.58%		-1,76
-1,65
-6.81%		-4,11
-2,00
-105.4%		-3,09
-1,32
-134.09%
-1,08


-0,71


-0,24


-0,36


-0,11

Net income
Million USD		Released
Forecast
Spread 		-0,11
-2,15
94.83%		-2,16
-2,38
9.45%		-5,79
-1,80
-221.83%		-8,21
-0,76
-979.74%		-1,74
-2,10
17.19%		-4,03
-2,09
-92.92%		-1,76
-1,65
-6.81%		-9,17
-2,00
-358.45%		-3,59
-1,32
-172.27%
-1,08


-0,71


-0,24


-0,36


-0,11

EPS
USD		Released
Forecast
Spread 		0,00
-36,8
- 		-49,0
-42,9
-14.29%		-123
-36,8
-233.33%		-152
-12,8
-1086.3%		-29,8
-31,9
6.59%		-44,5
-19,4
-128.83%		-13,0
-14,2
8.64%		-46,6
-10,5
-343.33%		-5,25
-5,25
0%
-3,15


-2,10


-0,35


-0,88


0,00

Announcement Date12/05/2211/08/2214/11/2230/03/2311/05/2310/08/2309/11/2326/03/2409/05/24-----

Upcoming sector events for NovaBay Pharmaceuticals, Inc.

15/07/2024 06:45 ADDLIFE AB: Q2 2024 Earnings Release
21/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
23/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
23/07/2024 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
24/07/2024 LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 06:00 BACHEM HOLDING AG: Q2 2024 Earnings Release
25/07/2024 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 06:00 BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for NovaBay Pharmaceuticals, Inc.

29/05/2024 21:01 IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 12:00 CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 06:00 EVOTEC SE: Q1 2024 Earnings Release
21/05/2024 22:14 ALVOTECH: Q1 2024 Earnings Release
21/05/2024 12:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
17/05/2024 07:00 BIOARCTIC AB: Q1 2024 Earnings Release
15/05/2024 21:05 CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release
14/05/2024 21:05 KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. NBY Stock
  4. Stock
  5. Calendar NovaBay Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW